Addex Therapeutics's total assets for Q3 2024 were CHF12.17M, a decrease of -11.16% from the previous quarter. ADXN total liabilities were CHF1.11M for the fiscal quarter, a 5.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.